Work

Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV

Year: 2006

Type: article

Source: Journal of Antimicrobial Chemotherapy

DOI: 10.1093/jac/dkl399

Authors: G. Friedland, S. Khoo, C. Jack, U. Lalloo

Institutions: Yale University, University of KwaZulu-Natal, University of Liverpool

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Wellcome Trust

OpenAlex ID: W2146921865

FWCI: 6.161

Cites: 8

Cited by: 117

Related to: 10